Winter 2015 : Noted ovarian cancer expert receives prestigious award
Noted ovarian cancer expert receives prestigious award
IGCS Award of Excellence recognizes Gershenson's myriad achievements
David M. Gershenson, M.D. Photo by John Smallwood.
The International Gynecology Cancer Society (IGCS) presented David Gershenson, M.D., professor and past chair of Gynecologic Oncology and Reproductive Medicine, its Award for Excellence at its November meeting in Melbourne, Australia. The honor recognizes Gershenson’s advancement of scientific knowledge, specifically of rare nonepithelial ovarian cancers, his unique breadth of experience, and his collaborative and consultative efforts with experts around the world.
Gershenson, who joined MD Anderson in 1979 and served as the department’s chair from 1998 to 2012, has held leadership roles in numerous national and international organizations. He continues to conduct clinical and translational studies with colleagues at MD Anderson and beyond.
“Our understanding of the disease’s molecular biology and genetics has transformed the field and led to dramatic opportunities in personalized medicine,” says Gershenson. “Over the past decade, we’ve transitioned from treating all ovarian cancers identically to targeting specific cancer subtypes.”
Gershenson is most proud of ushering in the next generation of gynecologic oncologists to make a difference in patients’ lives.
“Our patients teach us humility, priorities and the importance of living life to the fullest. In return, it’s vital that we offer them the very best possible care,” he says.
More Stories From Promise

A message from Dr. DePinho
A word from the president

Energizing the effort to end cancer
Oil and gas industry adds significant fuel to the fight

Moon Shots Program
As of January 31, 2015, private philanthropic commitments to the program
total more than $217.5 million.

My Moon Shot
David Ekas, a melanoma survivor and Marathon Oil Company employee,
established the Oilfield Melanoma Moon Shot Fund with a $20,000 personal
commitment. He reflects on his motivation to encourage others to support
the Melanoma Moon Shot and his hope for a cure.

Stripes aligns with MD Anderson
Convenience store campaign raises millions for children with cancer

Guided by a beacon of hope
Survivor finds strength in team of 20,000

iPromise
Lawrence and Alma Turner, of Houston, are high school sweethearts who
recently celebrated their 65th wedding anniversary. Lawrence is a
three-time cancer survivor, a registered Professional Engineer and a
World War II veteran. Alma is a two-time cancer survivor. Here, Lawrence
reflects on the miracles they've found at MD Anderson.

Survivors Say
Sheryl Barnes is a chronic lymphocytic leukemia (CLL) survivor of 33
years from Bloomington, Ind. Here, she reflects on the miracles that
awaited her at MD Anderson after almost 20 years of treatment elsewhere.

A hole in one for cancer research
Luncheon honors golfing legend

Head for the cure
Head for the Cure (HFTC), a 5K and Kids Fun Run benefiting brain cancer
research, returned to the Houston area in September and raised $66,000.

Coaching greats leave it all on the stage
Luncheon raises record-breaking funds for the Moon Shots Program

Winter bash provides fun in the sun for patients
Supporters deliver opportunity for kids to be kids

The joke's on brain cancer
Broach Foundation finds hope in humor

Compassion inspires cholangiocarcinoma support
Foundation supports collaborative basic research to target new treatments

'Why not shoot for the moon'
Couple gives $500,000 to Breast and Ovarian Cancers Moon Shot

An inspired gift
Family's loss to ovarian cancer spurs investment in hope

Jin honored to the tune of $100,000
Young Investigator Award reflects music industry support for sarcoma research

MD Anderson researcher receives top Italian science award
Previous recipients include two U.S. Nobel laureates

Gardasil 9
The Food and Drug Administration's (FDA) approval of a new vaccine that
targets five additional strains of human papilloma virus (HPV) fortifies
a proven cancer prevention weapon, says MD Anderson President Ron DePinho.

New integrated breast screening, diagnostic programs available
MD Anderson-Memorial Hermann partnership creates neighborhood access to
imaging services

A tribute to knowledge and dedication
Eight MD Anderson faculty members named AAAS Fellows

Divide and conquer
Research uncovers novel regulatory mechanism for cell division

A prickly pathway
Hedgehog gives green light to breast cancer spread

One gene leads to another
Findings point to power behind master cancer gene

Drug duo shows promise for MDS/AML patients
Study sheds light on dosage details